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Abstract
Background: Facial clefts are common birth defects with a strong genetic component. To identify fetal genetic risk factors
for clefting, 1536 SNPs in 357 candidate genes were genotyped in two population-based samples from Scandinavia
(Norway: 562 case-parent and 592 control-parent triads; Denmark: 235 case-parent triads).
Methodology/Principal Findings: We used two complementary statistical methods, TRIMM and HAPLIN, to look for
associations across these two national samples. TRIMM tests for association in each gene by using multi-SNP genotypes
from case-parent triads directly without the need to infer haplotypes. HAPLIN on the other hand estimates the full
haplotype distribution over a set of SNPs and estimates relative risks associated with each haplotype. For isolated cleft lip
with or without cleft palate (I-CL/P), TRIMM and HAPLIN both identified significant associations with IRF6 and ADH1C in both
populations, but only HAPLIN found an association with FGF12. For isolated cleft palate (I-CP), TRIMM found associations
with ALX3, MKX, and PDGFC in both populations, but only the association with PDGFC was identified by HAPLIN. In addition,
HAPLIN identified an association with ETV5 that was not detected by TRIMM.
Conclusion/Significance: Strong associations with seven genes were replicated in the Scandinavian samples and our
approach effectively replicated the strongest previously known association in clefting—with IRF6. Based on two national
cleft cohorts of similar ancestry, two robust statistical methods and a large panel of SNPs in the most promising cleft
candidate genes to date, this study identified a previously unknown association with clefting for ADH1C and provides
additional candidates and analytic approaches to advance the field.
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Introduction
With an average worldwide prevalence of 1.2/1000 live births,
facial clefts are the most common craniofacial birth defects and
one of the most common major types of defect in humans [1]. The
extensive surgical, dental and speech involvement, as well as
potential psychological sequelae, underscore the importance of
elucidating the causes of these complex facial defects. Analysis of
familial recurrence, segregation, and concordance in twins have
provided compelling evidence for a very strong genetic component
to clefting [2]. In Norway, for example, the risk among first-degree
relatives is approximately 40-fold higher than in the general
population [3]. However, the joint contribution of genetic variants
has to date accounted for only a modest fraction of the recognized
etiologies [4].
The past few years have witnessed major strides in the mapping
of facial cleft loci, with the list of genes rapidly expanding from the
first reported association of TGFA [MIM 190170] with isolated
PLoS ONE | www.plosone.org 1 April 2009 | Volume 4 | Issue 4 | e5385cleft lip with or without cleft palate (I-CL/P) in 1989 [5] to now
include IRF6 [MIM 607199], MSX1 [MIM 142983], TGFB3
[MIM 190230], FOXE1 [MIM 602617], FGFR1 [MIM 136350],
FGFR2 [MIM 176943], FGF8 [MIM 600483], PDGFC [MIM
608452], CRISPLD2 [MIM 612434], PVRL1 [MIM 600644],
GABRB3 [MIM 137192], MSX2 [MIM 123101], SATB2 [MIM
608148], TBX10 [MIM 604648], TBX22 [MIM 300307], GLI2
[MIM 165230], JAG2 [MIM 602570], MTHFR [MIM 607093],
RARA [MIM 180240], LHX8 [MIM 604425], SKI [MIM 164780]
and SPRY2 [MIM 602466], among the many promising candidate
genes for clefts [2,4,6,7,8,9,10,11,12]. Although linkage studies
have been successful in mapping a number of these key candidate
genes [8], studies relying on linkage disequilibrium (LD) have
grown in popularity because they can be more effective in
detecting weaker associations from multiple common and low-
penetrance alleles [13,14]. Further, analyses based on haplotypes
can outperform single-point analyses in which multiple SNPs in a
gene are interrogated one at a time, because haplotypes can
increase the overall information content at a given locus [15] and
potentially capture association signals from variants that have not
been directly typed [16].
We adopted this LD-based approach in the current search for
fetal genetic risk factors for I-CL/P and isolated cleft palate (I-CP).
A total of 1536 SNPs were selected in 357 candidate genes for
facial clefts and genotyped in two population-based samples from
Scandinavia (Norway and Denmark). The multi-SNP genotype
data were analyzed using two complementary statistical methods,
TRIMM [15] and HAPLIN [17], to detect multi-marker
transmission distortion and to look for consistency in genetic
associations across the two national samples.
Methods
Participants
A nationwide case-control study of facial clefts in Norway
(1996–2001) provided 562 case-parent triads and 592 control-
parent triads for analysis. The overall study design and
characteristics of the study participants have been described
elsewhere [18]. Of the 562 case-parent triads, 114 were I-CP and
311 were I-CL/P. An additional 69 I-CP and 166 I-CL/P triads
were available from a population-based study of facial clefts in
Denmark (1991–2001) [19].
Candidate genes and SNP selection
Candidate genes for facial clefts were selected from a variety of
resources, including published linkage and association studies on
clefts, genome-wide scans, gene-knockout experiments in mice,
studies of chromosomal rearrangements in humans, and gene
expression analyses in human and mouse embryonic tissues
[2,4,20,21,22,23]. The Craniofacial and Oral Gene Expression
Network (COGENE; http://hg.wustl.edu/COGENE) catalogs
human gene expression changes during early embryonic develop-
ment and contains expression profiles on 25 different tissues/stages
in the craniofacial region of human embryos [21]. We searched
the Serial Analysis of Gene Expression (SAGE) libraries to see
whether a particular gene of interest is expressed in the relevant
embryonic tissues at the pertinent developmental stage (weeks 5–6
for fusion of the embryonic lip; weeks 7–10 for fusion of the palatal
shelves [24]).
Candidate genes were also chosen from two other global
approaches for studying gene function. The first is the mouse
mutagen N-ethyl-N-nitrosourea (ENU) project, which aims to
characterize the functions of genes on mouse chromosome 11
(syntenic to human chromosome 17) by saturating the chromosome
with point mutations [25]. The second approach is to query the
Developmental Genome Anatomy Project (DGAP; http://www.
bwhpathology.org/dgap/default.aspx) database using the search
option‘craniofacial: includingclefts, cranial abnormalitiesordefects
such as microcephaly’. DGAP identifies chromosomal rearrange-
ments in patients with multiple congenital anomalies and uses these
rearrangements to map and identify genes that are disrupted or
dysregulated in critical stages of human development [26].
Finally, Mendelian forms of clefting provide another important
avenue for identifying genes that may underlie the more common
and isolated forms of clefts, especially if these syndromic forms can
occasionally manifest as phenocopies of isolated clefts (e.g. Van der
Woude syndrome, VWS [MIM 119300]). The Online Mendelian
Inheritance in Man (OMIM; http://www.ncbi.nlm.nih.gov/
Omim) maintains a catalog of human genes and genetic disorders,
providing a rich resource for selecting candidate genes for clefts.
Using the search query ‘cleft lip OR cleft palate’, 439 entries were
retrieved from OMIM.
Using the above strategies, we compiled a list of 357 candidate
genes that may contribute to facial cleft etiology (Table S1). To
guide the selection of SNPs, the genome browser of the
International HapMap Consortium (http://www.hapmap.org)
was used to retrieve genotype data on these 357 candidate genes.
We used genotypes from the CEPH samples of Northern and
Western European ancestry for consistency with our white study
populations. SNPs were also selected from additional databases:
dbSNP (http://www.ncbi.nlm.nih.gov/projects/SNP); Japanese
SNP database (JSNP; http://snp.ims.u-tokyo.ac.jp); genome
browser at UCSC (http://genome.ucsc.edu); CHIP bioinfor-
matics tools (http://snpper.chip.org/bio/); and Seattle SNPs
(http://pga.mbt.washington.edu). The following criteria were used
to prioritize SNP selection: prior evidence of an association with
facial clefts; haplotype-tagging properties; minor allele frequency
(MAF) of at least 10%; and a preference for coding SNPs and
SNPs located in putative regulatory regions in the UTRs. SNPs
with high MAFs are more likely to have arisen on ancestral
chromosomes, making them more useful in assessing the degree of
LD in the Norwegian and Danish populations. Intragenic and
regulatory SNPs are more likely to be of functional importance,
while haplotype-tagging SNPs (htSNPs) are valuable in that they
use LD to extract the maximum amount of genetic information
from a particular haplotype block and to possibly tag for SNPs
with an unrecognized biological function.
A combination of software, including HAPLOVIEW (http://
www.broad.mit.edu/haploview/haploview; [27]), Best Enumera-
tion of SNP Tags (BEST; http://www.genomethods.org/best/
index.htm; [28]), and SNP Browser
TM (Applied Biosystems;
Foster City, CA), was used to evaluate MAF, inter-marker
distance, as well as LD patterns and haplotype block structures
for the selection of htSNPs. SNP assays were designed by Illumina
(http://www.illumina.com; San Diego, CA) and a ‘design score’
was computed for each SNP using an algorithm that rigorously
tests the performance of that SNP on an Illumina GoldenGate
TM
platform (Illumina, San Diego, CA). Approximately 10% more
SNPs than the full panel of 1536 SNPs were initially submitted to
allow flexibility in choosing substitute SNPs for those with poor
design scores. After multiple rounds of SNP evaluations, a custom
panel of 1536 SNPs was finalized for the 357 genes (Table S2).
Genotyping was done by the US Center for Inherited Disease
Research (CIDR; http://www.cidr.jhmi.edu).
Data cleaning
The within- and between-plate genotype reproducibility rates of
96 duplicate DNA samples and three additional samples that were
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genotyping. A SNP was deemed to have failed if fewer than 95%
of the samples generated a genotype at the locus. SNPs with low
minor allele frequency (MAF,1%) were also excluded due to their
lack of statistical power. Deviations from HWE in control samples
may indicate the presence of systematic genotyping errors, latent
population substructure, or a biological effect such as natural
selection [29,30,31]. For the Triad Multi-Marker test [15]
(TRIMM; see below), deviation from HWE (p,0.05) was used
to search for assay problems directly, since the validity of TRIMM
does not require SNPs to be in HWE. SNPs that showed deviation
from HWE in all of the following three sample sets: parents in
Norwegian case triads, parents in Norwegian control triads, and
parents in Danish triads, were deemed to be problematic and three
additional SNPs were removed based on this criterion.
To screen for Mendelian inconsistencies within families, we
used PedCheck [32]. Families with excessive Mendelian inconsis-
tencies are probably the result of sample switches or misidentified
paternity. We retained families with fewer than 10 inconsistencies
and removed eighteen families with 65 or more Mendelian
inconsistencies from the analyses (there were no families with
between 10 to 64 Mendelian inconsistencies).
After data cleaning, the final number of SNPs available for
analysis was 1315 in 334 candidate genes on autosomal
chromosomes, with one to twelve SNPs typed per gene, four
SNPs on average (see Tables S1 and S2 for details).
Data analysis
In this study, we investigated genes on autosomal chromosomes
only. Two complementary methods, TRIMM [15] and HAPLIN
[17], were used to analyze the case-parent triad genotype data.
TRIMM is a robust and intuitive statistical method for association
testing using multi-SNP genotype data from case-parent triads. It
uses the genotypes directly, obviating the need for either a HWE
assumption or haplotype phase inference. TRIMM identifies
transmission distortion for sets of SNPs by comparing the
genotypes of the offspring with those of the hypothetical
‘‘complement’’ child who would have inherited the two parental
alleles not transmitted to the observed affected offspring at each
locus. The LD structure is preserved in this hypothetical offspring.
The difference between the two offspring genotype vectors has
an expected value of zero at each locus, under the null hypothesis
of no linkage or no association with the disease locus under study.
Statistical significance of the test is evaluated by randomly
permuting the case-versus-complement labels for the pair of
offspring from each family, i.e. randomizing the sign of the
difference vector. In our analysis, we used the sum_logP test,
which is constructed to optimize over scenarios where risk depends
on a single studied SNP and also over scenarios where risk instead
depends on a multi-SNP susceptibility haplotype. TRIMM can
make full use of individuals with sporadic missing SNP data and
has no limitation on the number of SNPs it can handle. All
genotyped SNPs in a gene were thus used in the analyses.
HAPLIN (version 2.5) infers haplotypes from the unphased
family genotype data when possible, using the Expectation
Maximization (EM) algorithm. It estimates the disease relative
risk for haplotypes that have a frequency high enough to be
detected. The overall significance of the haplotypes is evaluated by
a likelihood ratio test, or alternatively, a score test. HAPLIN can
distinguish between single and double dose effects of haplotypes,
but to reduce the number of parameters needed to be estimated in
a multi-SNP scan, haplotype effects were assumed multiplicative in
our analyses. Also, haplotypes with population frequency less than
1% were removed from the analyses.
A typical observation when constructing haplotypes with more
than four SNPs is that the population LD structure dictates a large
number of rare haplotypes, complicating the estimation. In our
data, many of the genes with more than four SNPs displayed low
LD between the SNPs at the outer ends. Using window lengths of
more than four SNPs would thus generate many rare and perhaps
irrelevant haplotypes. For the I-CL/P cleft category, we restricted
HAPLIN to use four SNPs at a time with a sliding, overlapping
window approach to cover all SNPs in a gene. Because
considerably fewer cases were available for the analysis of I-CP,
we used only three SNPs in the sliding-window for this cleft
category. Within a gene, this produces a score test p-value for each
window, and the smallest p-value was chosen. To adjust this p-
value for within-gene multiple testing, the principle of ‘seemingly
unrelated estimation’ [33] was used. The individual (family) score
contributions for each window were saved and their between-
window correlations were used to correct the p-value.
We plotted the p-values from TRIMM and HAPLIN analyses
using a Schweder-Spjøtvoll plot [34], which is a simple graphical
procedure for the simultaneous evaluations of many tests. If none
of the genes are truly associated with facial clefts, the p-values
would fall along the straight sloping line. Conversely, the p-values
would deviate from this line in the presence of genes that are truly
associated with the disorder. Statistical analyses were carried out
on the Norwegian and Danish samples separately, and p-values
from these two sources were combined using Fisher’s method [35].
Fisher-combined p-values can be further corrected for multiple
testing using the Bonferroni correction.
To test for within-gene differences in genotype frequency across
the two national samples, we used all the case-parents in each triad.
The test is based on computing the chi-squared value for each SNP
in a given gene, followed by aggregating these values to obtain the
within-gene sum chi-squared value. These were then converted to
p-values using a permutation test with 1000 permutations (implying
that the smallest p-value estimable is 0.001). The permutations
permute the nationality label of each individual over all SNPs in a
gene simultaneously, thus compensating for LD.
All analyses by TRIMM and HAPLIN were restricted to
isolated clefts only, and were performed separately for the two
major categories of clefts—I-CL/P and I-CP. Software for
implementing TRIMM and HAPLIN are available for the R
[36] computing environment from our web sites (TRIMM: http://
www.niehs.nih.gov/research/atniehs/labs/bb/staff/weinberg/in-
dex.cfm#downloads; HAPLIN: http://www.uib.no/smis/gjes-
sing/genetics/software/haplin).
Ethics approval
Approval for this study was obtained from the Norwegian Data
Inspectorate, the Regional Committee on Research Ethics for
Western Norway, and the respective Institutional Review Boards
of the US National Institute of Environmental Health Sciences
(NIH/NIEHS) and the University of Iowa. For the Danish facial
clefts study, approval was obtained from The Danish National
Committee on Biomedical Research Ethics. Clinicopathological
information from all participating families and biologic specimens
for DNA extraction were obtained with the written informed
consent of the mothers and fathers, and all aspects of this research
were in compliance with the tenets of the Declaration of Helsinki for
human research (http://www.wma.net).
Results
This study was designed with the specific aim of identifying
consistent genetic associations across two population-based cleft
Genetic Risk of Facial Clefts
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candidate genes that were selected a priori for their potential roles
in clefting. We observed a high duplicate reproducibility rate
(99.98%), high Mendelian consistency rate (99.93%), and a low
rate of missing genotypes (0.55%) in the data. After removing
SNPs with more than 10 Mendelian errors and those with
significant deviations from HWE (p,0.05), the final number of
SNPs analyzed was 1315, representing a total of 334 candidate
genes on autosomal chromosomes (Tables S1 and S2).
Tables S3, S4, S5, S6 summarize the results of the TRIMM
and HAPLIN analyses by cleft type (I-CL/P vs. I-CP) and study
population (Norway vs. Denmark). The corresponding Schweder-
Spjøtvoll plots of p-values are provided in Figures 1 and 2. For I-
CL/P, HAPLIN and TRIMM identified strong associations with
IRF6 and ADH1C [MIM 103730] in both the Norwegian and
Danish sample. In addition to these, HAPLIN identified FGF12
[MIM 605802] in both populations. For I-CP, HAPLIN identified
strong associations with PDGFC and ETV5 [MIM 601600] in both
populations. While TRIMM confirmed the association with
PDGFC, it also identified additional associations with ALX3
[MIM 606014] and MKX (MIM entry not available for this gene).
The quantile-quantile (QQ) plots of Fisher-combined p-values
from the TRIMM and HAPLIN analyses in the two samples are
shown in Figure 3. Compared with the QQ plot for I-CP, the
QQ plot for I-CL/P displays an excess of small p-values.
Finally, Figure 4 provides a graphical summary of the main
results, diagrams the genomic location of the seven genes showing
associations, and details the type and position of the SNPs within
each gene.
Discussion
Of the 334 autosomal cleft candidate genes analyzed in this study,
associations with seven genes—IRF6, PDGFC, ADH1C, MKX, ALX3,
Figure 1. TRIMM analyses of the Norwegian and Danish samples. Schweder-Spjøtvoll plot of p-values for (A) isolated cleft lip with or without
cleft palate (I-CL/P) and (B) isolated cleft palate (I-CP). All genes with p-values #0.1 are shown on the X-axis and ordered according to observed p-
values (Y-axis). Genes with p-values #0.05 are highlighted in red. The sloping line represents the expected uniform distribution under the null (of no
effect). Genes with p-values #0.1 in both the Norwegian and Danish samples are indicated by vertical lines connecting the upper (Norway) and lower
(Denmark) plots.
doi:10.1371/journal.pone.0005385.g001
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from Norway and Denmark. As expected with this large number of
statistical tests, there were many more associations with p-values
,0.05 in each population. Of 334 candidate genes, 17 false positives
(p,0.05) in each cleft category in each country would be expected by
chance alone, and fewer than one gene would show replication across
the two countries. As shown in Figures 1 and 2,s i g n i f i c a n t
associations were found with 27 genes for I-CL/P and 21 genes for I-
CP in the Norwegian and Danish sample respectively using TRIMM
and/or HAPLIN. Since all candidate genes in this study were chosen
ap r i o r ifor their potential roles in facial clefting, it is important to
separate true associations from spurious ones. We will therefore focus
this discussion on genetic associations that were replicated in both
populations and that produced the smallest p-values.
TRIMM and HAPLIN analyses
I-CL/P—IRF6, ADH1C and FGF12. We initially
hypothesized similar genetic contributions to clefting in both
populations because of the shared ancestry of the Norwegian and
Danish populations. The genes for interferon regulatory factor 6
(IRF6), alcohol dehydrogenase 1C (ADH1C), and fibroblast growth
factor 12 (FGF12) were strongly associated with I-CL/P in both
populations using TRIMM and/or HAPLIN. An even larger
number of genes were significantly associated in one population
but not the other. Many are no doubt merely chance associations,
although a few may reflect true risk genes with associations too
weak to emerge in both Danish and Norwegian samples.
The role of IRF6 in facial clefting is now well established
[37,38,39,40,41,42,43,44], and our findings provide proof-of-
principle that this study design can reliably detect gene/SNP
combinations where the relative risks are relatively low. ADH1C is
the third gene of the class I alcohol dehydrogenase family
consisting of ADH1A, ADH1B, and ADH1C. These genes are
tandemly organized as a gene-cluster on chromosome 4q21–q23
and encode the alpha, beta and gamma subunits responsible for
most of the ethanol-oxidizing capacity in the liver [45]. The
Figure 2. HAPLIN analyses of the Norwegian and Danish samples. Schweder-Spjøtvoll plot of p-values for (A) isolated cleft lip with or
without cleft palate (I-CL/P) and (B) isolated cleft palate (I-CP). All genes with p-values #0.1 are shown on the X-axis and ordered according to
observed p-values (Y-axis). Genes with p-values #0.05 are highlighted in red. The sloping line represents the expected uniform distribution under the
null (of no effect). Genes that had p-values #0.1 in both the Norwegian and Danish samples are indicated by vertical lines connecting the upper
(Norway) and lower (Denmark) plots.
doi:10.1371/journal.pone.0005385.g002
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acetaldehyde at a lower rate than the major gamma 1 variant [46].
Furthermore, the gamma 2 allele also appears to have a protective
effect on the risk of facial clefts [47].
Alcohol consumption during the first trimester of pregnancy is
a recognized risk factor for facial clefts [4]. Our recent analysis of
maternal binge drinking in the same Norwegian sample
suggested that women who reported binge drinking were more
likely to have an infant with either CL/P or CP [48]. However,
our preliminary analyses show no evidence of interaction
between variants in ADH1C and maternal alcohol consumption
(results not shown). Previous support for a role of ADH1C in
facial clefting stems from an exploratory study from the US
where 64 candidate genes were investigated in a combined
sample of 58 I-CL/P and I-CP case-parent triads [49]. Despite
the small number of triads analyzed in that study, the strong
association with ADH1C persisted even after correcting for
multiple comparisons.
Figure 3. Quantile-quantile (QQ) plots of p-values. The QQ plot compares the distribution of the observed Fisher-combined p-values (2log
scale) for both populations with an expected uniform distribution under the null (sloping line). The plots for I-CL/P and I-CP are provided separately
for TRIMM in (A) and (B), respectively, and the corresponding plots for HAPLIN are shown in (C) and (D). Gene labels for the top six most significant
genes are displayed in each plot.
doi:10.1371/journal.pone.0005385.g003
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in our analyses. Although numerous studies have investigated
several members of the FGF and FGFR family in clefting, there
are no previously published association studies with FGF12
specifically. The FGF signaling pathway is known to play a
crucial role in craniofacial development [50], and when dysreg-
ulated causes craniosynostosis and other facio-skeletal malforma-
tions in humans [51]. Using a combination of direct sequencing,
association studies and in silico protein modeling, our group
recently showed that the FGF signaling pathway may contribute to
as much as 3–5% of I-CL/P [11].
Our data also suggest population-specific differences in
susceptibility to facial clefts. For example, both HAPLIN and
TRIMM identified FOXE1 as being significantly associated with I-
CL/P in the Danish sample, but a significant association did not
emerge in the larger Norwegian sample. Conversely, both
methods identified MSX1 among the genes most significantly
associated with I-CL/P in the Norwegian sample, whereas no such
association was seen in the Danish sample (Figures 1 and 2).
Although these findings do not contradict our previously reported
associations with these genes [9,52,53], this population-specific
susceptibility nevertheless highlights the problem with lack of
replication across diverse populations [54,55].
Among other genes significantly associated with facial clefts in
one population but not the other, zinc finger homeobox 1b
(ZFHX1B [MIM 605802]; a.k.a. ZEB2) is of particular interest.
Mutations in this gene underlie the autosomal dominant Mowat-
Wilson syndrome (MWS [MIM 235730]), characterized by severe
Figure 4. Genomic location of the seven genes identified in both populations by TRIMM and HAPLIN. Fisher-combined p-values are
shown for all genes with p-values #0.05 in both the Norwegian and Danish populations for either analysis. The distance between genes on the same
chromosome is indicated in megabases (Mb). Gene structure is shown in red for coding regions and blue for untranslated regions, with exon boxes
connected by intron lines. The seven identified genes are on the minus strand compared to the reference sequence and are scaled relative to one
another based on the length shown in kilobases (kb). Each SNP is represented by a symbol for its functional status as indicated at the bottom of the
figure. Two SNPs represented by a square with a star were considered in the region of IRF6, but actually fell within the neighboring gene TRAF3IP3.
doi:10.1371/journal.pone.0005385.g004
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Among the wide range of clinical features associated with MWS,
a small subset of patients also present with facial clefts [57]. In the
mouse model, cranial neural crest cells fail to dissociate and
migrate when Zfhx1b is knocked out [58]. These cells are early
progenitors of craniofacial cartilage, bone, and facial connective
tissue. It is thus plausible that a failure of the cells to delaminate
could underlie the distinctive facies and occasional clefting seen in
MWS patients.
The paralog Zfhx1a (a.k.a. Zeb1) when knocked out in mice
causes a cleft palate phenotype with 100% penetrance [59,60].
The defect appears to be largely due to a delay in palatal elevation.
In addition, the Zfhx1a null embryos also show reduced expression
of Jag2, Tgfb3 and Mmp13—genes known to be involved in
palatogenesis. There also appears to be complex synergistic
interactions between Zfhx1a and Zfhx1b during mouse embryo-
genesis [61]. Notably, the double Zfhx1a/Zfhx1b mutants have
midline defects at the fusion sites of the nasal and maxillary
processes.
I-CP—ALX3, MKX, PDGFC and ETV5. TRIMM and
HAPLIN identified four genes strongly associated with I-CP in
both populations. Aristaless (ALX)-related genes are a subset of the
Paired-related homeobox genes involved in the development of
craniofacial structures [62,63]. ALX3 encodes a nuclear protein
containing a homeobox DNA-binding domain that functions as a
transcriptional regulator in embryonic development. In mice,
expression of Alx3 is highly localized and the characteristic
expression pattern suggests an important role in patterning of
neural-crest derived mesenchyme and shaping of craniofacial
structures [64]. Compound mutants of Alx3 and Alx4 exhibit
severe craniofacial abnormalities that are otherwise absent in Alx4
single mutants [65]. In addition, Alx3/Alx4 double mutant newborn
micehavecleft nasal regions, mostlikely as a result of a failure of the
medial nasal processes to fuse in the facial midline [65].
The mohawk homeobox (MKX) gene product is another
important regulator of vertebrate development [66]. In mice, Mkx
is expressed in somite-derived cell lineages that give rise to skeletal
muscle, among other cell types [67]. Mkx was formerly described as
Irxl1 (iroquois homeobox protein-like 1) in Liu et al. [68]. Localized
in the middle of the 4.3 Mb critical region in the spontaneous
Twirler mouse mutant, Mkx is a likely candidate for the Twirler (Tw)
gene. Mice heterozygous for the Twirler mutation have inner ear
defects, whereas those homozygous have cleft lip and cleft palate.
Mkx is also highly expressed in the palatal mesenchyme during
palatal growth and fusion [68]. Interestingly, both MKX and
ZFHX1A (a paralog of ZFHX1B described above) are located within
the10p15-11regionwhichisassociated withcleftlipand cleftpalate
when duplicated [69], but not when deleted [70]. Finally, Blanton
and co-workers have reported strong associations between markers
from the 10p13 region and I-CL/P [71].
Compared with ALX and MKX, the gene for platelet-derived
growth factor C (PDGFC) has a well-substantiated role in
palatogenesis. Linkage, association and cytogenetic studies have
supported the existence of a CL/P locus in the chromosome 4q31-
ter region containing the PDGFC locus [70,72,73,74]. More
recently, Choi and colleagues showed that a SNP in the PDGFC
regulatory region decreased promoter transcriptional activity and
was associated with CL/P in multiple populations [75]. Animal
studies have also shown a specific role for PDGFC in palatal
development. For example, Pdgfc
2/2 mice die in the perinatal
period, presumably due to feeding and respiratory difficulties from
having a complete cleft of the secondary palate [6]. In these mice,
the palatal bones fail to extend across the roof of the oral-nasal
cavity, suggesting that hypoplasia of palate tissues combined with
fusion defects of the medial edge epithelia may contribute to the
cleft palate seen in the Pdgfc
2/2 mice [6]. In vitro PDGFC, a potent
stimulator of mitosis, is downregulated by retinoic acid in mouse
embryonic palatal mesenchymal cells [76]. Reduced PDGFC by
retinoic acid may cause inhibition of proliferation in palatal
shelves, resulting in the pathogenesis of cleft palate in Pdgfc
2/2
mice or retinoic acid-treated mice. Consistent with the absence of
cleft lip in Pdgfc
2/2 mice, the association with PDGFC was found
exclusively in the I-CP group in our data.
Lastly, the gene encoding transcription factor ETV5 (ets variant
5) is located on chromosome 3q28 (as FGF12 above). In the E13.5
mouse palatal epithelium, expression of Etv5 is strong on the oral
surface of the palatal shelf and overlaps to some extent with that of
the FGF signaling antagonist Spry2 [77]. Mice carrying a deletion
that disrupts Spry2 have cleft palate, and point mutations in SPRY2
may be rare causes of I-CL/P [9]. The link between ETV5, SPRY2
and members of the FGF family offers an exciting opportunity to
further explore these interacting developmental pathways in the
pathogenesis of cleft palate.
Methodological aspects
Multiple testing. Both TRIMM and HAPLIN correct for
within-gene multiple testing, ensuring the validity of the individual
p-values for each gene. When assessing the overall results, no
single gene remained significant after a full Bonferroni correction.
However, it is generally agreed that the Bonferroni requirement of
ensuring an overall type 1 error rate of below 5% is too strict and
may result in too many false negatives [78], particularly in this
study where the selected genes already had an a priori connection
to clefting. As an alternative, we focused here on genes showing
significance in both populations. As proof-of-principle, our
approach consistently replicated the previously known strong
associations with IRF6 and PDGFC, while proposing several new
candidate genes including ETV5, FGF12, MKX, ADH1C and ALX3
for further analyses.
Quantile-quantile (QQ) plot. A QQ plot compares the
observed p-values with the expected uniform distribution under
the null when multiple tests are performed. If the plot reveals a
marked difference between the expected and observed p-value
distribution, this may indicate that a number of genes are
significantly associated with disease, although individual genes
may not have a marginal effect that is strong enough to withstand
Bonferroni correction. We used the plot to test for within-gene
differences in SNP genotype distribution across the two national
samples, as well as to evaluate the results of the genetic association
tests by TRIMM and HAPLIN.
Our data revealed systematic differences in genotypes for a
subset of the SNPs across the Norwegian and Danish samples.
These differences cannot be simply ascribed to random genotyping
errors, as these had already been filtered out by our initial HWE
check and data-cleaning steps. Biases in genotype call rates may
arise if DNA comes from different sources (e.g. blood versus buccal
swab). However, the genotype call rates were 99.6% for DNA
extracted from blood (Norwegian sample) and 99.1% for DNA
extracted from buccal swabs (Danish sample). Even if the marked
heterogeneity is a true indication of population differences,
different genotype frequencies do not imply differences in gene-
effects on phenotype. Moreover, our methods, based on analysis of
case-parent triads, insulate against population-based differences of
this kind.
QQ plots of the combined p-values from the TRIMM and
HAPLIN analyses for I-CL/P and I-CP are depicted in Figure 3.
Of the two cleft categories, the QQ plot for I-CP showed the least
evidence of association with the selected SNPs, yet this is the cleft
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are real but weak genetic effects, these would still be expected to
deviate from the uniform distribution. The lack of associated genes
in I-CP may be a direct consequence of insufficient SNP coverage
rather than a lack of statistical power. Also, there may be
important gene-gene/gene-environment interactions that were not
considered in the current analyses.
SNP resolution. Our selection of htSNPs was based
primarily on genotype information publicly available from the
International HapMap Consortium. Although the use of
haplotypes may guard against the loss of power in detecting an
association signal, inadequate SNP resolution might still be a
concern in this study, as pointed out for the lack of associated
genes in I-CP. Adequate representation of the genetic architecture
of each candidate gene is feasible only if htSNPs are selected from
complete re-sequencing of the genes in the two populations
examined. Furthermore, the effect of SNP resolution on inferred
haplotype block structure is not fully understood. Studies using
lower marker density identify progressively longer blocks, and vice-
versa [80]. The small set of reference samples (30 CEPH trios) of
[Western] European descent in HapMap may not be sufficiently
representative of the Danish or Norwegian population, especially if
common alleles are overrepresented and rare alleles more strongly
linked to facial clefting are underrepresented. Hence, blocks
detected at low marker density may not adequately reflect the true
genetic diversity in our data.
HAPLIN and TRIMM. These two analytic methods are both
designed to detect multi-marker transmission distortion, but they
accomplish this in different ways. TRIMM is non-parametric and
can accommodate population structure, deviation from HWE,
multiple SNPs, missing SNPs and non-negligible recombination
rates. TRIMM does not attempt to infer haplotypes and,
consequently, is computationally efficient. TRIMM performs
best when there is one important risk haplotype or one SNP
associated with risk. When applied to a set of SNPs within a gene,
TRIMM accounts for within-gene SNP correlations by permuting
alleles at all SNPs simultaneously. HAPLIN on the other hand is
better suited to handle more complicated scenarios, for example,
when there is more than one risk-associated haplotype. Being
parametric, HAPLIN estimates the full haplotype distribution over
a set of SNPs and also estimates relative risks associated with each
haplotype. Through the use of a full maximum likelihood model, it
produces a complete description of the ‘‘risk structure’’ over the set
of haplotypes in a region. HAPLIN requires HWE, assumes no
recombination, and is computationally more demanding.
Of particular relevance to our analyses here is that if one of the
genotyped SNPs has a direct effect on disease risk, independently
of the other SNPs, TRIMM would be most likely to detect it.
Alternatively, if the specific risk locus has not been genotyped
directly, it is still likely to be associated with a haplotype composed
of SNPs measured in the surrounding region. Since HAPLIN
scans window-lengths of 3 and 4 SNPs, it will typically surround
such a locus with 1–2 SNPs on either side, provided the disease
locus resides within the genotyped region. In such cases, the
sliding-window approach of HAPLIN should have a better chance
of detecting the true association.
Replication of findings. Replication has a central role in the
evaluation of association findings, particularly in studies involving
large numbers of statistical tests [55]. To help separate true
associationsfromspuriousones,we lookedforassociationsthat were
consistent across the two populations of shared ancestry, which are
more likely to represent true associations as opposed to spurious
associations that show up randomly—even in populations of similar
ancestralbackground.We opted not tocombinethe Norwegianand
Danish samples (although this would have boosted power) because
we had no prior data to assume that the same haplotype(s)
contribute to the risk of clefts in both populations. Although our
data do not speak to that issue, our test for heterogeneity between
these two populations showed marked and systematic differences in
genotypes for a subset of the SNPs (data not shown), suggesting
ancestral differences between the two populations.
Concluding remarks
In this search among 357 candidate genes for facial clefting, we
found a relatively small number of genes to be significantly
associated with either I-CL/P or I-CP. The modest number of
genes associated with this strongly genetic birth defect has several
possible interpretations. It may suggest the presence of etiological
variants not genotyped in the current study (copy number variants
for example), or cleft candidate genes overlooked in our gene
selection. It may also reflect the effects of non-additive interactions
with other genetic variants and/or with environmental factors that
have been and will be explored in other studies [81]. Furthermore,
it is possible that the remaining genetic risks arise in the context of
allelic heterogeneity, in which case they would not be detectable
by the current LD-based association approach. We have analyzed
only individual genes; epistasis between these may play an
important role as well. There is also the possibility that, regardless
of apparent similarities between the Norwegian and Danish
populations, these two populations may have inherently distinct
genetic susceptibilities to facial clefting.
The use of two powerful and complementary statistical methods
for haplotype analysis of genetic data from offspring-parent triads,
two well-defined cleft phenotypes, two national cleft cohorts of
similar ancestry, and the use of a very large number of SNPs in
many genes (10 times the number of SNPs previously used to look
for cleft associations), provided a powerful opportunity to look for
associations that are most likely to be genuine. Our approach
effectively replicated the strongest previously known association
with cleft lip—the one with IRF6—in both populations and by
both methods, and suggested new associations with ADH1C and
PDGFC. Finally, the novel genes detected here (MKX, ALX3,
ETV5, and FGF12) provide new insights for future analyses of this
common and complex birth defect.
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